The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with chronic renal failure
Luis Gruberg, MD*,
Ron Waksman, MD, FACC*,
Andrew E. Ajani, MD*,
Han-Soo Kim, MD*,
R. Larry White, MD ,
Ellen Pinnow, MS*,
Regina Deible, RN*,
Lowell F. Satler, MD, FACC*,
Augusto D. Pichard, MD, FACC*,
Kenneth K. Kent, MD, PhD, FACC* and
Joseph Lindsay, Jr, MD, FACC*
* Washington Hospital Center, Washington, D.C., USA
Washington Cancer Institute at the Washington Hospital Center, Washington, D.C., USA

View larger version (13K):
[in a new window]
|
Figure 1 Binary restenosis rates, target lesion revascularization rates (TLR) and target vessel revascularization rates (TVR) at six-month angiographic follow-up in chronic renal failure patients treated with either intracoronary radiation (white bar) or placebo (black bar).
|
|
|